OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Medical Screening is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Aptima HPV E6/E7 mRNA and cytology cross-sectional performance as primary screening tests for detection of high-grade cervical lesions in HIV positive and negative women in South Africa	41
“DNA tests for every baby on the NHS”	35
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening	34
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review	29
An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway–Impact on radiologist person-years, costs and effects	22
Simulated arbitration of discordance between radiologists and artificial intelligence interpretation of breast cancer screening mammograms	22
Risk stratification in medical screening	21
Timely adherence to follow-up after high-risk lung cancer screenings	17
Carrier rate of thalassemia among 25,910 high school students in Shaoguan area, China	17
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality	17
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes	15
Percentage mammographic density or absolute breast density for risk stratification in breast screening: Possible implications for socioeconomic health disparity	15
Applying the healthcare failure mode and effects analysis approach to improve the quality of an organised colorectal cancer screening programme	13
Systematic review and meta-analysis of colon capsule endoscopy accuracy for colorectal cancer screening. An alternative during the Covid-19 pandemic?	11
Response to the letter: “Ethics of screening promotion: A slippery slope to forced marketing?”	10
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study	9
The Risk-Screening Converter: Use of multiple risk factors	9
Effects of COVID-19 pandemic on breast cancer screening: A 6-year cohort study	8
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing	8
Screen-detected ductal carcinoma in situ, 2008–2020: An observational study	8
Implementation of a centralized HPV-based cervical cancer screening programme in Tuscany: First round results and comparison with the foregoing Pap-based screening programme	8
The Risk-Screening Converter	7
Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines	7
Cancer screening after the age of 75: Nationwide population-based trends	7
Cancer screening programs in Japan: Progress and challenges	6

Trends in colorectal cancer screening in the United States, 2012 to 2020	5
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis	5
Age at breast cancer screening in women with intellectual disability	5
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening	5
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada	5
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study	5
Folic acid and neural tube defects: Discovery, debate and the need for policy change	5
Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test	4
Response to ‘Six-week postnatal cervical screening: Moving from acceptability toward mechanistic evidence and policy change’	4
The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy	4
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis	4
Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection de	4
Colorectal cancer screening with faecal immunochemical test: Patterns of participation	4
Skin cancer screening recommendations by U.S. cancer centers: Inconsistency with national guidelines	4
Comments on “Effects of COVID-19 pandemic on breast cancer screening” by Huang et al. https://doi.org/10.1177/09691413251338456	4
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India	4
Quality indicators for cervical screening in Sweden	4